Pharmazeutische Erzeugnisse-Aktien
Vollständige Übersicht aller 250 börsennotierten Unternehmen der Branche Pharmazeutische Erzeugnisse. Vergleichen Sie Marktkapitalisierung, Bewertungs-KGV, Dividendenrendite und Insider-Scores im direkten Wettbewerbsvergleich.
Die Branche Pharmazeutische Erzeugnisse im Sektor Gesundheit umfasst aktuell 250 börsennotierte US-Unternehmen mit einer aggregierten Marktkapitalisierung von 5,81 Bio. $. Gemessen an der Marktkapitalisierung wird die Branche von ELI LILLY & Co (LLY), JOHNSON & JOHNSON (JNJ), BeOne Medicines Ltd. (ONC) angeführt. Mit einem Median-KGV von 19,5 spiegelt die Branche das Bewertungsniveau im Sektor Gesundheit wider. Die höchsten quantitativen Insider- und Conviction-Scores weisen aktuell LFCR (Score 74) sowie CPIX (Score 73) auf. Klicken Sie auf ein beliebiges Unternehmen, um dessen vollständige SEC-Form-4-Meldungen, Eigentümerstruktur und Peer-Group-Matrix zu analysieren.
| # | Unternehmen / Ticker | Marktkapitalisierung | Letzter Kurs | KGV | Dividende | Insider-Score | Analyse |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & Co | 1,07 Bio. $ Mega Cap | 1.142,85 $ | 50,1 | 0,5 % | 67 | Details › |
| 2 | JNJ JOHNSON & JOHNSON | 639,0 Mrd. $ Mega Cap | 256,03 $ | 23,2 | 0,4 % | 59 | Details › |
| 3 | ONC BeOne Medicines Ltd. | 540,2 Mrd. $ Mega Cap | 358,07 $ | 1.884,6 | — | 45 | Details › |
| 4 | ABBV AbbVie Inc. | 468,5 Mrd. $ Mega Cap | 262,82 $ | 111,4 | 2,5 % | 60 | Details › |
| 5 | MRK Merck & Co., Inc. | 350,6 Mrd. $ Mega Cap | 144,30 $ | 19,8 | 2,3 % | 68 | Details › |
| 6 | NVS NOVARTIS AG | 269,9 Mrd. $ Mega Cap | 141,00 $ | 19,5 | 2,9 % | 53 | Details › |
| 7 | AZN ASTRAZENECA PLC | 252,0 Mrd. $ Mega Cap | 156,90 $ | 23,7 | 1,8 % | 72 | Details › |
| 8 | AMGN AMGEN INC | 214,7 Mrd. $ Mega Cap | 403,04 $ | 28,3 | 2,5 % | 57 | Details › |
| 9 | GILD GILEAD SCIENCES, INC. | 182,6 Mrd. $ Mega Cap | 144,74 $ | 21,3 | 2,2 % | 54 | Details › |
| 10 | NVO NOVO NORDISK A S | 169,3 Mrd. $ Mega Cap | 37,32 $ | 1,6 | 3,9 % | 65 | Details › |
| 11 | PFE PFIZER INC | 161,0 Mrd. $ Mega Cap | 27,80 $ | 20,4 | 6,2 % | 59 | Details › |
| 12 | VRTX VERTEX PHARMACEUTICALS INC / MA | 134,1 Mrd. $ Mega Cap | 504,73 $ | 32,9 | — | 67 | Details › |
| 13 | BMY BRISTOL MYERS SQUIBB CO | 126,1 Mrd. $ Mega Cap | 61,15 $ | 17,8 | 4,1 % | 64 | Details › |
| 14 | CSLLY CSL LTD | 117,0 Mrd. $ Mega Cap | 30,54 $ | — | 3,7 % | 37 | Details › |
| 15 | GSK GSK plc | 100,1 Mrd. $ Mega Cap | 47,03 $ | 16,7 | 3,4 % | 53 | Details › |
| 16 | REGN REGENERON PHARMACEUTICALS, INC. | 71,6 Mrd. $ Mega Cap | 735,20 $ | 17,7 | — | 52 | Details › |
| 17 | MRNA Moderna, Inc. | 70,1 Mrd. $ Mega Cap | 190,01 $ | — | — | 30 | Details › |
| 18 | ARGX ARGENX SE | 61,6 Mrd. $ Mega Cap | 919,21 $ | 43,6 | — | 50 | Details › |
| 19 | TAK TAKEDA PHARMACEUTICAL CO LTD | 58,2 Mrd. $ Mega Cap | 17,86 $ | 0,3 | 3,4 % | 71 | Details › |
| 20 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 46,8 Mrd. $ Mega Cap | 39,53 $ | 32,7 | — | 50 | Details › |
| 21 | HLN Haleon plc | 40,7 Mrd. $ Mega Cap | 8,80 $ | 24,2 | 1,8 % | 54 | Details › |
| 22 | KVUE Kenvue Inc. | 33,4 Mrd. $ Mega Cap | 17,20 $ | 22,6 | 4,8 % | 70 | Details › |
| 23 | BIIB BIOGEN INC. | 33,2 Mrd. $ Mega Cap | 219,88 $ | 25,0 | — | 69 | Details › |
| 24 | ALNY ALNYLAM PHARMACEUTICALS, INC. | 31,5 Mrd. $ Mega Cap | 219,72 $ | 94,3 | — | 45 | Details › |
| 25 | ZLAB Zai Lab Ltd | 29,9 Mrd. $ Mega Cap | 24,33 $ | — | — | 33 | Details › |
| 26 | ZTS Zoetis Inc. | 29,2 Mrd. $ Mega Cap | 69,69 $ | 11,6 | 2,9 % | 68 | Details › |
| 27 | FUJIY FUJI PHOTO FILM CO LTD /FI | 25,8 Mrd. $ Mega Cap | 10,66 $ | 0,1 | 2,4 % | 38 | Details › |
| 28 | INSM INSMED Inc | 24,4 Mrd. $ Mega Cap | 111,12 $ | — | — | 28 | Details › |
| 29 | INCY INCYTE CORP | 24,0 Mrd. $ Mega Cap | 115,30 $ | 18,0 | — | 67 | Details › |
| 30 | UTHR UNITED THERAPEUTICS Corp | 21,3 Mrd. $ Mega Cap | 541,70 $ | 20,5 | — | 56 | Details › |
| 31 | VTRS Viatris Inc | 19,7 Mrd. $ Mega Cap | 17,60 $ | — | 0,7 % | 67 | Details › |
| 32 | NBIX NEUROCRINE BIOSCIENCES INC | 15,4 Mrd. $ Mega Cap | 143,18 $ | 30,7 | — | 61 | Details › |
| 33 | JAZZ Jazz Pharmaceuticals plc | 15,2 Mrd. $ Mega Cap | 235,67 $ | — | — | 61 | Details › |
| 34 | ASND Ascendis Pharma A/S | 14,7 Mrd. $ Mega Cap | 227,87 $ | — | — | 57 | Details › |
| 35 | EXEL EXELIXIS, INC. | 14,2 Mrd. $ Mega Cap | 58,39 $ | 21,0 | — | 60 | Details › |
| 36 | SMMT Summit Therapeutics Inc. | 13,2 Mrd. $ Mega Cap | 16,76 $ | — | — | 45 | Details › |
| 37 | CORT CORCEPT THERAPEUTICS INC | 12,3 Mrd. $ Mega Cap | 116,23 $ | 139,1 | — | 49 | Details › |
| 38 | MDGL MADRIGAL PHARMACEUTICALS, INC. | 11,7 Mrd. $ Mega Cap | 499,40 $ | — | — | 28 | Details › |
| 39 | BMRN BIOMARIN PHARMACEUTICAL INC | 11,7 Mrd. $ Mega Cap | 57,18 $ | 32,5 | — | 52 | Details › |
| 40 | ELAN Elanco Animal Health Inc | 11,1 Mrd. $ Mega Cap | 22,14 $ | — | — | 35 | Details › |
| 41 | RDY DR REDDYS LABORATORIES LTD | 10,1 Mrd. $ Mega Cap | 12,25 $ | 0,2 | 0,6 % | 51 | Details › |
| 42 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 9,6 Mrd. $ Large Cap | 64,19 $ | — | — | 43 | Details › |
| 43 | CYTK CYTOKINETICS INC | 9,0 Mrd. $ Large Cap | 65,60 $ | — | — | 39 | Details › |
| 44 | IONS IONIS PHARMACEUTICALS INC | 8,0 Mrd. $ Large Cap | 43,54 $ | — | — | 28 | Details › |
| 45 | ABVX Abivax S.A. | 7,9 Mrd. $ Large Cap | 92,88 $ | — | — | 46 | Details › |
| 46 | TGTX TG THERAPEUTICS, INC. | 7,9 Mrd. $ Large Cap | 54,29 $ | 19,6 | — | 63 | Details › |
| 47 | GPCR Structure Therapeutics Inc. | 7,9 Mrd. $ Large Cap | 27,67 $ | — | — | 47 | Details › |
| 48 | ALKS Alkermes plc. | 7,3 Mrd. $ Large Cap | 41,75 $ | 29,2 | — | 64 | Details › |
| 49 | IMVT Immunovant, Inc. | 7,3 Mrd. $ Large Cap | 33,62 $ | — | — | 42 | Details › |
| 50 | RYTM RHYTHM PHARMACEUTICALS, INC. | 6,7 Mrd. $ Large Cap | 92,83 $ | — | — | 34 | Details › |
| 51 | BLTE BELITE BIO, INC | 6,7 Mrd. $ Large Cap | 159,56 $ | — | — | 36 | Details › |
| 52 | LNTH Lantheus Holdings, Inc. | 6,6 Mrd. $ Large Cap | 99,96 $ | 29,3 | — | 59 | Details › |
| 53 | LGND LIGAND PHARMACEUTICALS INC | 6,2 Mrd. $ Large Cap | 302,96 $ | 49,4 | 0,8 % | 69 | Details › |
| 54 | GRFS Grifols SA | 6,1 Mrd. $ Large Cap | 7,31 $ | 12,9 | 2,3 % | 55 | Details › |
| 55 | AMRX Amneal Pharmaceuticals, Inc. | 6,1 Mrd. $ Large Cap | 20,30 $ | 92,3 | — | 68 | Details › |
| 56 | TVTX Travere Therapeutics, Inc. | 6,0 Mrd. $ Large Cap | 56,93 $ | — | — | 46 | Details › |
| 57 | KNSA Kiniksa Pharmaceuticals International, plc | 5,9 Mrd. $ Large Cap | 75,79 $ | 101,1 | — | 62 | Details › |
| 58 | MIRM Mirum Pharmaceuticals, Inc. | 5,8 Mrd. $ Large Cap | 82,93 $ | — | — | 58 | Details › |
| 59 | AMRN AMARIN CORP PLC\UK | 5,5 Mrd. $ Large Cap | 12,35 $ | — | — | 63 | Details › |
| 60 | ERAS Erasca, Inc. | 5,5 Mrd. $ Large Cap | 14,74 $ | — | — | 41 | Details › |
| 61 | PTCT PTC THERAPEUTICS, INC. | 5,1 Mrd. $ Large Cap | 63,46 $ | 8,2 | — | 61 | Details › |
| 62 | DFTX Definium Therapeutics, Inc. | 4,9 Mrd. $ Large Cap | 37,40 $ | — | — | 58 | Details › |
| 63 | MANE Veradermics, Inc | 4,7 Mrd. $ Large Cap | 116,76 $ | — | — | 40 | Details › |
| 64 | INDV Indivior Pharmaceuticals, Inc. | 4,3 Mrd. $ Large Cap | 35,71 $ | 21,8 | — | 53 | Details › |
| 65 | OGN Organon & Co. | 3,6 Mrd. $ Large Cap | 13,72 $ | 19,1 | 2,5 % | 62 | Details › |
| 66 | TARS Tarsus Pharmaceuticals, Inc. | 3,6 Mrd. $ Large Cap | 73,00 $ | — | — | 34 | Details › |
| 67 | AMLX Amylyx Pharmaceuticals, Inc. | 3,5 Mrd. $ Large Cap | 27,79 $ | — | — | 47 | Details › |
| 68 | TLX Telix Pharmaceuticals Ltd | 3,5 Mrd. $ Large Cap | 10,86 $ | — | — | 44 | Details › |
| 69 | ACAD ACADIA PHARMACEUTICALS INC | 3,4 Mrd. $ Large Cap | 19,95 $ | 8,6 | — | 54 | Details › |
| 70 | ARQT Arcutis Biotherapeutics, Inc. | 2,9 Mrd. $ Large Cap | 25,16 $ | — | — | 40 | Details › |
| 71 | LQDA Liquidia Corp | 2,8 Mrd. $ Large Cap | 28,64 $ | — | — | 38 | Details › |
| 72 | NAMS NewAmsterdam Pharma Co N.V. | 2,7 Mrd. $ Large Cap | 23,20 $ | — | — | 34 | Details › |
| 73 | HCM HUTCHMED (China) Ltd | 2,6 Mrd. $ Large Cap | 14,20 $ | 5,3 | — | 59 | Details › |
| 74 | IMNM Immunome Inc. | 2,5 Mrd. $ Large Cap | 20,90 $ | — | — | 35 | Details › |
| 75 | SUPN SUPERNUS PHARMACEUTICALS, INC. | 2,5 Mrd. $ Large Cap | 42,38 $ | — | — | 52 | Details › |
| 76 | PHVS Pharvaris N.V. | 2,4 Mrd. $ Large Cap | 31,19 $ | — | — | 45 | Details › |
| 77 | HRMY Harmony Biosciences Holdings, Inc. | 2,4 Mrd. $ Large Cap | 39,64 $ | 14,6 | — | 57 | Details › |
| 78 | ADMA ADMA BIOLOGICS, INC. | 2,1 Mrd. $ Large Cap | 9,72 $ | 16,2 | — | 65 | Details › |
| 79 | PBH Prestige Consumer Healthcare Inc. | 2,1 Mrd. $ Large Cap | 45,26 $ | 11,6 | — | 58 | Details › |
| 80 | BCRX BIOCRYST PHARMACEUTICALS INC | 2,1 Mrd. $ Large Cap | 8,17 $ | 6,8 | — | 67 | Details › |
| 81 | BHC Bausch Health Companies Inc. | 2,1 Mrd. $ Large Cap | 5,80 $ | 13,8 | 22,6 % | 54 | Details › |
| 82 | AUPH Aurinia Pharmaceuticals Inc. | 2,1 Mrd. $ Large Cap | 15,83 $ | 7,6 | — | 52 | Details › |
| 83 | TRVI Trevi Therapeutics, Inc. | 2,1 Mrd. $ Large Cap | 13,91 $ | — | — | 48 | Details › |
| 84 | PVLA PALVELLA THERAPEUTICS, INC. | 2,0 Mrd. $ Large Cap | 132,47 $ | — | — | 36 | Details › |
| 85 | SRPT Sarepta Therapeutics, Inc. | 2,0 Mrd. $ Large Cap | 17,50 $ | — | — | 36 | Details › |
| 86 | ALVO Alvotech | 2,0 Mrd. $ Mid Cap | 5,45 $ | 54,5 | — | 47 | Details › |
| 87 | URGN UroGen Pharma Ltd. | 2,0 Mrd. $ Mid Cap | 41,40 $ | — | — | 48 | Details › |
| 88 | AGIO AGIOS PHARMACEUTICALS, INC. | 1,9 Mrd. $ Mid Cap | 31,80 $ | — | — | 47 | Details › |
| 89 | NBTX Nanobiotix S.A. | 1,7 Mrd. $ Mid Cap | 25,75 $ | — | — | 30 | Details › |
| 90 | SNDX Syndax Pharmaceuticals Inc | 1,7 Mrd. $ Mid Cap | 17,60 $ | — | — | 29 | Details › |
| 91 | NVAX NOVAVAX INC | 1,7 Mrd. $ Mid Cap | 10,46 $ | 4,1 | — | 38 | Details › |
| 92 | STOK Stoke Therapeutics, Inc. | 1,7 Mrd. $ Mid Cap | 25,62 $ | — | — | 34 | Details › |
| 93 | ANIP ANI PHARMACEUTICALS INC | 1,7 Mrd. $ Mid Cap | 72,18 $ | 21,7 | — | 58 | Details › |
| 94 | XERS Xeris Biopharma Holdings, Inc. | 1,6 Mrd. $ Mid Cap | 9,08 $ | — | — | 59 | Details › |
| 95 | OCUL OCULAR THERAPEUTIX, INC | 1,6 Mrd. $ Mid Cap | 6,96 $ | — | — | 30 | Details › |
| 96 | AVBP ArriVent BioPharma, Inc. | 1,5 Mrd. $ Mid Cap | 28,27 $ | — | — | 42 | Details › |
| 97 | ETON Eton Pharmaceuticals, Inc. | 1,5 Mrd. $ Mid Cap | 55,36 $ | — | — | 45 | Details › |
| 98 | AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | 1,5 Mrd. $ Mid Cap | 14,74 $ | — | — | — | Details › |
| 99 | KLRA Kailera Therapeutics, Inc. | 1,4 Mrd. $ Mid Cap | 9,95 $ | — | — | 52 | Details › |
| 100 | INVA Innoviva, Inc. | 1,4 Mrd. $ Mid Cap | 20,50 $ | 6,2 | — | 70 | Details › |
| 101 | RARE Ultragenyx Pharmaceutical Inc. | 1,4 Mrd. $ Mid Cap | 15,22 $ | — | — | 42 | Details › |
| 102 | MNKD MANNKIND CORP | 1,3 Mrd. $ Mid Cap | 3,80 $ | 190,0 | — | 47 | Details › |
| 103 | AVLN Avalyn Pharma Inc. | 1,2 Mrd. $ Mid Cap | 28,13 $ | — | — | 60 | Details › |
| 104 | SVRA Savara Inc | 1,1 Mrd. $ Mid Cap | 4,81 $ | — | — | 43 | Details › |
| 105 | AMPH Amphastar Pharmaceuticals, Inc. | 1,1 Mrd. $ Mid Cap | 25,43 $ | 12,5 | — | 52 | Details › |
| 106 | HROW HARROW, INC. | 1,1 Mrd. $ Mid Cap | 30,48 $ | — | — | 38 | Details › |
| 107 | ANRO Alto Neuroscience, Inc. | 1,1 Mrd. $ Mid Cap | 24,80 $ | — | — | 35 | Details › |
| 108 | GLUE Monte Rosa Therapeutics, Inc. | 1,0 Mrd. $ Mid Cap | 10,50 $ | — | — | 27 | Details › |
| 109 | PAHC PHIBRO ANIMAL HEALTH CORP | 1,0 Mrd. $ Mid Cap | 37,24 $ | 14,8 | 1,4 % | 68 | Details › |
| 110 | SPTX Seaport Therapeutics, Inc. | 1,0 Mrd. $ Mid Cap | 17,73 $ | — | — | 49 | Details › |
| 111 | CGEM Cullinan Therapeutics, Inc. | 1,0 Mrd. $ Mid Cap | 15,51 $ | — | — | 42 | Details › |
| 112 | CRVS Corvus Pharmaceuticals, Inc. | 971,2 Mio. $ Mid Cap | 10,90 $ | — | — | 31 | Details › |
| 113 | PCRX Pacira BioSciences, Inc. | 946,3 Mio. $ Mid Cap | 25,21 $ | 157,6 | — | 65 | Details › |
| 114 | KURA Kura Oncology, Inc. | 941,3 Mio. $ Mid Cap | 10,65 $ | — | — | 46 | Details › |
| 115 | SGP SpyGlass Pharma, Inc. | 909,4 Mio. $ Mid Cap | 24,92 $ | — | — | 29 | Details › |
| 116 | HELP Helus Pharma Inc. | 899,9 Mio. $ Mid Cap | 11,70 $ | — | — | 47 | Details › |
| 117 | TBPH Theravance Biopharma, Inc. | 887,6 Mio. $ Mid Cap | 17,03 $ | 8,3 | — | 69 | Details › |
| 118 | GERN GERON CORP | 815,1 Mio. $ Mid Cap | 1,20 $ | — | — | 39 | Details › |
| 119 | ACHV ACHIEVE LIFE SCIENCES, INC. | 813,3 Mio. $ Mid Cap | 7,24 $ | — | — | 22 | Details › |
| 120 | GYRE GYRE THERAPEUTICS, INC. | 785,7 Mio. $ Mid Cap | 7,11 $ | 355,5 | 3,4 % | 40 | Details › |
| 121 | COLL COLLEGIUM PHARMACEUTICAL, INC | 717,7 Mio. $ Mid Cap | 22,02 $ | 12,7 | — | 64 | Details › |
| 122 | LXRX LEXICON PHARMACEUTICALS, INC. | 707,2 Mio. $ Mid Cap | 1,82 $ | — | — | 42 | Details › |
| 123 | VSTM Verastem, Inc. | 700,1 Mio. $ Mid Cap | 7,70 $ | — | — | 35 | Details › |
| 124 | NVCT Nuvectis Pharma, Inc. | 694,5 Mio. $ Mid Cap | 21,92 $ | — | — | 46 | Details › |
| 125 | PHAR Pharming Group N.V. | 689,6 Mio. $ Mid Cap | 9,75 $ | 248,8 | — | 41 | Details › |
| 126 | ZVRA ZEVRA THERAPEUTICS, INC. | 658,7 Mio. $ Mid Cap | 9,99 $ | 7,4 | — | 61 | Details › |
| 127 | ANNX Annexon, Inc. | 635,7 Mio. $ Mid Cap | 4,19 $ | — | — | 26 | Details › |
| 128 | IRWD IRONWOOD PHARMACEUTICALS INC | 625,4 Mio. $ Mid Cap | 3,64 $ | 24,3 | — | 61 | Details › |
| 129 | AQST Aquestive Therapeutics, Inc. | 586,6 Mio. $ Mid Cap | 4,55 $ | — | — | 26 | Details › |
| 130 | CRMD CorMedix Inc. | 585,8 Mio. $ Mid Cap | 7,19 $ | 3,5 | — | 65 | Details › |
| 131 | EOLS Evolus, Inc. | 507,3 Mio. $ Mid Cap | 7,14 $ | — | — | 58 | Details › |
| 132 | OCS Oculis Holding AG | 494,4 Mio. $ Mid Cap | 8,73 $ | — | — | 34 | Details › |
| 133 | KMDA KAMADA LTD | 468,1 Mio. $ Mid Cap | 8,31 $ | 23,7 | 3,0 % | 58 | Details › |
| 134 | IRD Opus Genetics, Inc. | 415,9 Mio. $ Mid Cap | 4,58 $ | — | — | 50 | Details › |
| 135 | RZLT Rezolute, Inc. | 413,4 Mio. $ Mid Cap | 4,01 $ | — | — | 46 | Details › |
| 136 | SPRY ARS Pharmaceuticals, Inc. | 408,9 Mio. $ Mid Cap | 4,07 $ | — | — | 32 | Details › |
| 137 | AVIR Atea Pharmaceuticals, Inc. | 404,7 Mio. $ Mid Cap | 5,13 $ | — | — | 42 | Details › |
| 138 | FENC FENNEC PHARMACEUTICALS INC. | 380,9 Mio. $ Mid Cap | 10,20 $ | — | — | 42 | Details › |
| 139 | BBOT BridgeBio Oncology Therapeutics, Inc. | 339,2 Mio. $ Mid Cap | 3,89 $ | — | — | 25 | Details › |
| 140 | QNRX Quoin Pharmaceuticals Ltd. | 330,2 Mio. $ Mid Cap | 4,47 $ | — | — | 41 | Details › |
| 141 | TTRX Turn Therapeutics Inc. | 328,3 Mio. $ Mid Cap | 12,23 $ | — | — | 50 | Details › |
| 142 | XFOR X4 Pharmaceuticals, Inc | 314,8 Mio. $ Mid Cap | 2,83 $ | — | — | 38 | Details › |
| 143 | EBS Emergent BioSolutions Inc. | 305,6 Mio. $ Mid Cap | 6,33 $ | 6,8 | — | 69 | Details › |
| 144 | IVVD Invivyd, Inc. | 302,0 Mio. $ Mid Cap | 0,82 $ | — | — | 28 | Details › |
| 145 | VNDA Vanda Pharmaceuticals Inc. | 295,4 Mio. $ Small Cap | 4,63 $ | — | — | 51 | Details › |
| 146 | EYPT EyePoint, Inc. | 293,1 Mio. $ Small Cap | 3,25 $ | — | — | 28 | Details › |
| 147 | FULC Fulcrum Therapeutics, Inc. | 284,6 Mio. $ Small Cap | 3,69 $ | — | — | 32 | Details › |
| 148 | TLSI TriSalus Life Sciences, Inc. | 274,0 Mio. $ Small Cap | 4,32 $ | — | — | 50 | Details › |
| 149 | MREO Mereo BioPharma Group plc | 273,1 Mio. $ Small Cap | 0,38 $ | — | — | 56 | Details › |
| 150 | IFRX InflaRx N.V. | 266,9 Mio. $ Small Cap | 1,72 $ | — | — | 55 | Details › |
| 151 | MGNX MACROGENICS INC | 265,8 Mio. $ Small Cap | 3,58 $ | — | — | 53 | Details › |
| 152 | GLSI Greenwich LifeSciences, Inc. | 253,3 Mio. $ Small Cap | 16,98 $ | — | — | 30 | Details › |
| 153 | ELTP ELITE PHARMACEUTICALS INC /NV/ | 244,2 Mio. $ Small Cap | 0,23 $ | 7,6 | — | 50 | Details › |
| 154 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | 244,2 Mio. $ Small Cap | 6,54 $ | — | — | 74 | Details › |
| 155 | AKBA Akebia Therapeutics, Inc. | 242,8 Mio. $ Small Cap | 0,87 $ | — | — | 65 | Details › |
| 156 | ACB AURORA CANNABIS INC | 237,4 Mio. $ Small Cap | 3,92 $ | — | — | 60 | Details › |
| 157 | SIGA SIGA TECHNOLOGIES INC | 222,4 Mio. $ Small Cap | 3,38 $ | 10,6 | 19,2 % | 57 | Details › |
| 158 | SLGL Sol-Gel Technologies Ltd. | 219,1 Mio. $ Small Cap | 72,00 $ | — | — | 39 | Details › |
| 159 | PLX Protalix BioTherapeutics, Inc. | 214,5 Mio. $ Small Cap | 2,71 $ | — | — | 57 | Details › |
| 160 | ELDN Eledon Pharmaceuticals, Inc. | 207,4 Mio. $ Small Cap | 2,49 $ | — | — | 39 | Details › |
| 161 | ALEC Alector, Inc. | 205,3 Mio. $ Small Cap | 1,81 $ | — | — | 36 | Details › |
| 162 | CHRS Coherus Oncology, Inc. | 200,9 Mio. $ Small Cap | 1,16 $ | 0,8 | — | 39 | Details › |
| 163 | ANTX AN2 Therapeutics, Inc. | 198,0 Mio. $ Small Cap | 5,71 $ | — | — | 41 | Details › |
| 164 | ZNTL Zentalis Pharmaceuticals, Inc. | 190,1 Mio. $ Small Cap | 2,52 $ | — | — | 38 | Details › |
| 165 | ACOG Alpha Cognition Inc. | 188,9 Mio. $ Small Cap | 9,10 $ | — | — | 46 | Details › |
| 166 | CRDL Cardiol Therapeutics Inc. | 185,4 Mio. $ Small Cap | 1,41 $ | — | — | 36 | Details › |
| 167 | CUE Cue Biopharma, Inc. | 183,0 Mio. $ Small Cap | 25,57 $ | — | — | 39 | Details › |
| 168 | MDWD MediWound Ltd. | 169,4 Mio. $ Small Cap | 13,52 $ | — | — | 48 | Details › |
| 169 | TNXP Tonix Pharmaceuticals Holding Corp. | 168,6 Mio. $ Small Cap | 8,91 $ | — | — | 28 | Details › |
| 170 | DERM Journey Medical Corp | 167,5 Mio. $ Small Cap | 6,61 $ | — | — | 37 | Details › |
| 171 | NERV Minerva Neurosciences, Inc. | 165,1 Mio. $ Small Cap | 3,28 $ | — | — | 47 | Details › |
| 172 | NGEN NERVGEN PHARMA CORP. | 154,2 Mio. $ Small Cap | 1,78 $ | — | — | 50 | Details › |
| 173 | OTLK Outlook Therapeutics, Inc. | 145,2 Mio. $ Small Cap | 0,59 $ | — | — | 3 | Details › |
| 174 | MENS Jyong Biotech Ltd. | 140,2 Mio. $ Small Cap | 2,18 $ | — | — | — | Details › |
| 175 | NRXP NRX Pharmaceuticals, Inc. | 128,9 Mio. $ Small Cap | 2,91 $ | — | — | 32 | Details › |
| 176 | LENZ LENZ Therapeutics, Inc. | 120,3 Mio. $ Small Cap | 3,58 $ | — | — | 27 | Details › |
| 177 | BMEA Biomea Fusion, Inc. | 113,4 Mio. $ Small Cap | 1,27 $ | — | — | 40 | Details › |
| 178 | AARD Aardvark Therapeutics, Inc. | 110,8 Mio. $ Small Cap | 4,99 $ | — | — | 53 | Details › |
| 179 | MIST Milestone Pharmaceuticals Inc. | 109,8 Mio. $ Small Cap | 0,81 $ | — | — | 39 | Details › |
| 180 | CPIX CUMBERLAND PHARMACEUTICALS INC | 93,7 Mio. $ Small Cap | 7,39 $ | — | — | 73 | Details › |
| 181 | ICCC IMMUCELL CORP /DE/ | 89,7 Mio. $ Small Cap | 9,75 $ | — | — | — | Details › |
| 182 | PTHS Pelthos Therapeutics Inc. | 87,6 Mio. $ Small Cap | 20,60 $ | — | — | 32 | Details › |
| 183 | VTVT vTv Therapeutics Inc. | 87,3 Mio. $ Small Cap | 30,57 $ | — | — | 30 | Details › |
| 184 | VRCA Verrica Pharmaceuticals Inc. | 85,3 Mio. $ Small Cap | 4,38 $ | — | — | 45 | Details › |
| 185 | ACRV Acrivon Therapeutics, Inc. | 81,2 Mio. $ Small Cap | 1,99 $ | — | — | 58 | Details › |
| 186 | CNTB Connect Biopharma Holdings Ltd | 79,0 Mio. $ Small Cap | 0,93 $ | — | — | 31 | Details › |
| 187 | TELO Telomir Pharmaceuticals, Inc. | 77,7 Mio. $ Small Cap | 1,18 $ | — | — | — | Details › |
| 188 | PMVP PMV Pharmaceuticals, Inc. | 77,6 Mio. $ Small Cap | 1,79 $ | — | — | 50 | Details › |
| 189 | RNTX Rein Therapeutics, Inc. | 71,7 Mio. $ Small Cap | 0,80 $ | — | — | 29 | Details › |
| 190 | TENX TENAX THERAPEUTICS, INC. | 71,5 Mio. $ Small Cap | 1,98 $ | — | — | 35 | Details › |
| 191 | CTOR CITIUS ONCOLOGY, INC. | 68,6 Mio. $ Small Cap | 0,89 $ | — | — | 51 | Details › |
| 192 | SKYE Skye Bioscience, Inc. | 67,7 Mio. $ Small Cap | 1,68 $ | — | — | — | Details › |
| 193 | TLPH TALPHERA, INC. | 60,7 Mio. $ Small Cap | 1,13 $ | — | — | 64 | Details › |
| 194 | SPRO Spero Therapeutics, Inc. | 60,1 Mio. $ Small Cap | 1,19 $ | 7,9 | — | 44 | Details › |
| 195 | ATHE ALTERITY THERAPEUTICS LTD | 58,3 Mio. $ Small Cap | 3,45 $ | — | — | — | Details › |
| 196 | CLNN Clene Inc. | 52,3 Mio. $ Small Cap | 4,08 $ | — | — | 43 | Details › |
| 197 | EDSA Edesa Biotech, Inc. | 45,0 Mio. $ Micro Cap | 3,86 $ | — | — | 34 | Details › |
| 198 | GRCE Grace Therapeutics, Inc. | 42,5 Mio. $ Micro Cap | 2,07 $ | — | — | 43 | Details › |
| 199 | COSM Cosmos Health Inc. | 40,6 Mio. $ Micro Cap | 0,38 $ | — | — | 31 | Details › |
| 200 | PPCB Propanc Biopharma, Inc. | 40,6 Mio. $ Micro Cap | 0,51 $ | — | — | 19 | Details › |
| 201 | KAPA Kairos Pharma, LTD. | 40,1 Mio. $ Micro Cap | 1,56 $ | — | — | — | Details › |
| 202 | IXHL Incannex Healthcare Inc. | 39,6 Mio. $ Micro Cap | 3,21 $ | — | — | 38 | Details › |
| 203 | NNVC NANOVIRICIDES, INC. | 38,3 Mio. $ Micro Cap | 1,28 $ | — | — | 60 | Details › |
| 204 | ELAB PMGC Holdings Inc. | 38,2 Mio. $ Micro Cap | 3,36 $ | — | — | 31 | Details › |
| 205 | SCLX Scilex Holding Co | 38,1 Mio. $ Micro Cap | 4,06 $ | — | — | 50 | Details › |
| 206 | ATNM Actinium Pharmaceuticals, Inc. | 37,4 Mio. $ Micro Cap | 1,17 $ | — | — | — | Details › |
| 207 | KPTI Karyopharm Therapeutics Inc. | 36,2 Mio. $ Micro Cap | 0,80 $ | — | — | 7 | Details › |
| 208 | MTNB Matinas BioPharma Holdings, Inc. | 35,4 Mio. $ Micro Cap | 2,64 $ | — | — | 16 | Details › |
| 209 | ATYR aTYR PHARMA INC | 35,0 Mio. $ Micro Cap | 0,29 $ | — | — | 36 | Details › |
| 210 | RMTI ROCKWELL MEDICAL, INC. | 33,2 Mio. $ Micro Cap | 8,65 $ | — | — | 56 | Details › |
| 211 | CPHI CHINA PHARMA HOLDINGS, INC. | 30,4 Mio. $ Micro Cap | 0,66 $ | — | — | — | Details › |
| 212 | MIRA MIRA PHARMACEUTICALS, INC. | 30,2 Mio. $ Micro Cap | 0,73 $ | — | — | — | Details › |
| 213 | CNTX Context Therapeutics Inc. | 29,3 Mio. $ Micro Cap | 0,31 $ | — | — | 36 | Details › |
| 214 | KYNB KYNTRA BIO, INC. | 27,7 Mio. $ Micro Cap | 6,31 $ | 0,1 | — | 44 | Details › |
| 215 | QNCX Quince Therapeutics, Inc. | 27,3 Mio. $ Micro Cap | 29,20 $ | — | — | 28 | Details › |
| 216 | ABVC ABVC BIOPHARMA, INC. | 26,7 Mio. $ Micro Cap | 1,01 $ | — | — | 42 | Details › |
| 217 | IGC IGC Pharma, Inc. | 26,3 Mio. $ Micro Cap | 0,27 $ | — | — | 39 | Details › |
| 218 | AYTU AYTU BIOPHARMA, INC | 21,4 Mio. $ Micro Cap | 2,07 $ | — | — | — | Details › |
| 219 | CLRB Cellectar Biosciences, Inc. | 19,8 Mio. $ Micro Cap | 1,78 $ | — | — | 39 | Details › |
| 220 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | 16,1 Mio. $ Micro Cap | 4,17 $ | — | — | — | Details › |
| 221 | BFRI Biofrontera Inc. | 15,5 Mio. $ Micro Cap | 1,02 $ | — | — | 49 | Details › |
| 222 | AEON AEON Biopharma, Inc. | 15,2 Mio. $ Micro Cap | 0,28 $ | — | — | 32 | Details › |
| 223 | CTXR Citius Pharmaceuticals, Inc. | 14,8 Mio. $ Micro Cap | 0,53 $ | — | 113,1 % | — | Details › |
| 224 | ASBP Aspire-Lakewood Holdings, Inc. | 13,8 Mio. $ Micro Cap | 8,78 $ | — | — | 41 | Details › |
| 225 | BFRG BullFrog AI Holdings, Inc. | 13,4 Mio. $ Micro Cap | 0,62 $ | — | — | — | Details › |
| 226 | PHIO Phio Pharmaceuticals Corp. | 12,1 Mio. $ Micro Cap | 0,99 $ | — | — | — | Details › |
| 227 | ADIL ADIAL PHARMACEUTICALS, INC. | 11,4 Mio. $ Micro Cap | 4,12 $ | — | — | 19 | Details › |
| 228 | TRAW Traws Pharma, Inc. | 8,9 Mio. $ Micro Cap | 0,57 $ | 0,7 | — | — | Details › |
| 229 | ENSC Ensysce Biosciences, Inc. | 7,4 Mio. $ Micro Cap | 0,40 $ | — | — | 20 | Details › |
| 230 | MGRX MANGOCEUTICALS, INC. | 7,2 Mio. $ Micro Cap | 0,44 $ | — | — | 28 | Details › |
| 231 | ACXP Acurx Pharmaceuticals, Inc. | 6,7 Mio. $ Micro Cap | 1,27 $ | — | — | — | Details › |
| 232 | ENVB Enveric Biosciences, Inc. | 6,4 Mio. $ Micro Cap | 1,48 $ | — | — | — | Details › |
| 233 | TPST Tempest Therapeutics, Inc. | 6,3 Mio. $ Micro Cap | 0,81 $ | — | — | 14 | Details › |
| 234 | SNOA Sonoma Pharmaceuticals, Inc. | 6,0 Mio. $ Micro Cap | 1,24 $ | — | — | — | Details › |
| 235 | AIM AIM ImmunoTech Inc. | 5,8 Mio. $ Micro Cap | 0,18 $ | — | — | 30 | Details › |
| 236 | APUS Apimeds Pharmaceuticals US, Inc. | 5,7 Mio. $ Micro Cap | 3,22 $ | — | — | 30 | Details › |
| 237 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | 4,2 Mio. $ Micro Cap | 1,39 $ | — | — | — | Details › |
| 238 | CVKD Cadrenal Therapeutics, Inc. | 4,1 Mio. $ Micro Cap | 0,94 $ | — | 1.484,3 % | — | Details › |
| 239 | JAGX Jaguar Health, Inc. | 4,0 Mio. $ Micro Cap | 3,66 $ | — | — | 1 | Details › |
| 240 | ONCO Onconetix, Inc. | 3,6 Mio. $ Micro Cap | 0,73 $ | — | 137,6 % | 26 | Details › |
| 241 | UPC Universe Pharmaceuticals INC | 2,8 Mio. $ Micro Cap | 4,50 $ | — | — | 45 | Details › |
| 242 | LABT Lakewood-Amedex Biotherapeutics Inc. | 2,3 Mio. $ Micro Cap | 0,85 $ | — | — | — | Details › |
| 243 | JUNS JUPITER NEUROSCIENCES, INC. | 2,3 Mio. $ Micro Cap | 2,55 $ | — | — | — | Details › |
| 244 | RADX Radiopharm Theranostics Ltd | 2,1 Mio. $ Micro Cap | 1,42 $ | — | — | — | Details › |
| 245 | RDHL RedHill Biopharma Ltd. | 1,7 Mio. $ Micro Cap | 0,50 $ | — | — | — | Details › |
| 246 | SXTC China SXT Pharmaceuticals, Inc. | 1,4 Mio. $ Micro Cap | 2,41 $ | — | — | — | Details › |
| 247 | CMND Clearmind Medicine Inc. | 1,3 Mio. $ Micro Cap | 0,72 $ | — | — | — | Details › |
| 248 | IMCC IM Cannabis Corp. | 649.075 $ Micro Cap | 2,04 $ | — | — | 37 | Details › |
| 249 | PBM PSYENCE BIOMEDICAL LTD. | 119.132 $ Micro Cap | 5,16 $ | — | — | 39 | Details › |
| 250 | PRFX PRF Technologies Ltd. | 80.694 $ Micro Cap | 0,92 $ | — | — | — | Details › |
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.